Detailed price reference for bimetinib/bemetinib 20 tablets

Bimetinib/bemetinib (Binimetinib) is widely used in combination targeting regimens for specific types of melanoma in the field of targeted therapy, especially for BRAF V600 mutation-positive patients. In China, it has not yet been officially launched and has not been included in the medical insurance catalog, so it is still difficult to obtain accurate retail prices in domestic hospitals or pharmacies. Currently, patients mainly rely on cross-border drug purchases or third-party international medical channels to obtain the drug.

About bimetinibThe price of 20 tablets is not a common standard packaging specification in the actual market. Taking overseas markets as an example, the current most common specification of bimetinib’s original drug is 15 mg, with 84 or 168 tablets per box. Depending on the manufacturer and country’s pricing, the price of each box may be between 20,000 to 30,000 yuan. Since there is no separate pricing for 20 tablets, the price of 20 tablets can only be calculated through conversion, which can be roughly between RMB 4,000 and RMB 6,000. The specific price is affected by factors such as exchange rate fluctuations, supply channels, transportation costs, and drug taxes.

In addition, it is worth noting that generic versions of bimetinib have appeared in the international market, and pharmaceutical factories in some Southeast Asian countries, such as Laos and Bangladesh, have begun to produce generic drugs in 15 mg*180 tablets. The price is significantly lower than the original drug. For example, the version from Lucius Pharmaceutical Factory in Laos is priced at just over 6,000 yuan in some regular overseas pharmacies, but the price may still change due to channel and exchange rate fluctuations. Although these generic drugs are low-priced, patients need to pay special attention to the quality certification, consistency of ingredients, and safety of packaging and logistics when purchasing.

For patients who want to know the price, they can obtain the latest quotations and logistics arrangements through qualified cross-border drug purchasing platforms or overseas medical consulting services.

Reference materials:https://go.drugbank.com/drugs/DB11967